Skip to main content
All lobbying filings

EAST END GROUP, LLC

Lobbying for ALVOGEN · Pharmaceutical company developing and manufacturing generic, brand and biosimilar products

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $45,000.00 income · posted Jul 17, 2025

Official filing document

 Lobbying activity 1
Health Issues

Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem